BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector

H. Yamamoto, M. Ishimura, M. Ochiai, H. Takada, K. Kusuhara, Y. Nakatsu, T. Tsuzuki, K. Mitani, T. Hara

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

X-linked agammaglobulinemia (XLA) is one of the most common humoral immunodeficiencies, which is caused by mutations in Bruton's tyrosine kinase (BTK) gene. To examine the possibility of using gene therapy for XLA, we constructed a helper-dependent adenovirus/adeno-associated virus BTK targeting vector (HD-Ad.AAV BTK vector) composed of a genomic sequence containing BTK exons 6-19 and a green fluorescence protein-hygromycin cassette driven by a cytomegalovirus promoter. We first used NALM-6, a human male pre-B acute lymphoblastic leukemia cell line, as a recipient to measure the efficiency of gene targeting by homologous recombination. We identified 10 clones with the homologous recombination of the BTK gene among 107 hygromycin-resistant stable clones isolated from two independent experiments. We next used cord blood CD34+ cells as the recipient cells for the gene targeting. We isolated colonies grown in medium containing cytokines and hygromycin. We found that the targeting of the BTK gene occurred in four of the 755 hygromycin-resistant colonies. Importantly, the gene targeting was also observed in CD19+ lymphoid progenitor cells that were differentiated from the homologous recombinant CD34+ cells during growth in selection media. Our study shows the potential for the BTK gene therapy using the HD-Ad.AAV BTK vector via homologous recombination in hematopoietic stem cells.

Original languageEnglish
Pages (from-to)205-213
Number of pages9
JournalGene Therapy
Volume23
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector'. Together they form a unique fingerprint.

  • Cite this